Two leading boutiques in the healthcare and life science sectors – Vintura and Cepton – have merged to form a consultancy with around 90 staff across four European markets.
“This merger is a key step in our transformation journey to become the leading international life science and healthcare management boutique,” said Gérard Klop, the founder of Netherlands-based Vintura.
Jean Reboullet, the founding partner of Cepton, added: “The joining of forces will solidify our presence in Europe, provide new opportunities and access to other healthcare markets and clients, as well as augment our respective portfolios.”
Founded in 2000, Vintura helps clients in the healthcare and life sciences sectors with strategy, organisation and change. The consulting firm has a team of 55 consultants and staff working from offices in the Netherlands, Germany and the United Kingdom. Its clients include the likes of EIT Health, Janssen, Roche, and several hospitals.
Established in 2006, Cepton is a healthcare specialist focused on strategy and management consulting services. The 35-strong Paris-based firm is mainly active in the French market, serving mid-market players and private equity groups.
For both consultancies, the move adds scale and a presence in new markets. “To have maximum impact, we believe you need to share your client’s language and culture, be near and have knowledge of and experience within the local healthcare system,” explained Klop.
The merger also provides complementary lines of business to the firms. While Vintura and Cepton share a portfolio of strategy and organisation capabilities, Cepton brings in new expertise in transaction due diligence and value optimisation services to financial sponsors. Meanwhile, Vintura complements Cepton’s healthcare portfolio with specific expertise in the care and cure segments.
“Both companies strongly believe in the power of diversified offerings and being able to bring new perspectives to clients,” said Klop.
For Reboullet, the deal additionally builds on similar high-end reputations in the marketplace and cultural values. In France, Cepton has been named by Capital and Statista among the country’s top pharma consulting firms, among others, while in the Netherlands, Vintura ranks as one of the country’s leading consultancies in both healthcare and life sciences.
“It’s a merger of equal minds and we have a similar culture,” concluded Reboullet.
Both management consulting firms will continue to operate under their current brands. Financial details of the transaction have not been disclosed.